Spinal Hydromorphone Versus Morphine for Post-Cesarean Delivery Analgesia

PHASE4CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

November 11, 2020

Primary Completion Date

July 28, 2022

Study Completion Date

July 28, 2022

Conditions
Postoperative Pain
Interventions
DRUG

Spinal Hydromorphone

75 mcg of hydromorphone will be prepared in a non-identifiable syringe by central hospital pharmacy. The resulting solution will then be added to the spinal anesthetic mixture(fentanyl 15 mcg and 0.75% hyperbaric bupivacaine 1.4-1.6 mcg at the discretion of the attending anesthesiologist, adjusted to height and weight)

DRUG

Spinal Morphine

150 mcg of morphine will be prepared in a non-identifiable syringe by central hospital pharmacy.The resulting solution will be added to the spinal anesthetic mixture (fentanyl 15 mcg and 0.75% hyperbaric bupivacaine 1.4-1.6 mcg at the discretion of the attending anesthesiologist, adjusted to height and weight)

Trial Locations (1)

N6A 5A5

Victoria Hospital- LHSC, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT03592992 - Spinal Hydromorphone Versus Morphine for Post-Cesarean Delivery Analgesia | Biotech Hunter | Biotech Hunter